Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2/STAT3 signalling pathway

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 3, 2013, Pages 339-345

  Liu, Yun Yi ^a   Zheng, Qian ^a   Fang, Bin ^a   Wang, Wei ^a   Ma, Feng Yun ^a   Roshan, Sadia ^a   Banafa, Amal ^a   Chen, Ming Jie ^a   Chang, Jun Li ^a   Deng, Xiao Min ^a   Li, Ke Xiu ^a   Yang, Guang Xiao ^a   He, Guang Yuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

apoptosis; germacrone; HepG2 cells; JAK2 STAT3

Indexed keywords

GERMACRONE; HERBACEOUS AGENT; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; SESQUITERPENE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; DOSE RESPONSE; DRUG EFFECT; HEPG2 CELL LINE; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HEP G2 CELLS; HUMANS; JANUS KINASE 2; SESQUITERPENES, GERMACRANE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84879301043     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1121-z     Document Type: Article

References (30)

1. Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol, 2010,52(2):252-257
2. Giuliani J, Marzola M. Multidisciplinary approach as the key factor in the management of liver metastases from colorectal cancer. J Gastrointest Cancer, 2012:1-3
3. Chang ML, Lin SM, Yeh CT. HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer. Plos One, 2011,6(10):e26323
4. de Lope CR, Tremosini S, Forner A, et al. Management of HCC. J Hepatol, 2012,56Suppl 1:S75-87
5. Narimatsu S, Kariya S, Isozaki S, et al. Involvement of CYP2D6 in oxidative metabolism of cinnarizine and flunarizine in human liver microsomes. Biochem Biophys Res Commun, 1993,193(3):1262-1268
6. Robertson Remen KM, Gustafsson JA, Andersson G. The liver X receptor promotes macrophage differentiation and suppresses osteoclast formation in mouse RAW264.7 promyelocytic leukemia cells exposed to bacterial lipopolysaccharide. Biochem Biophys Res Commun, 2013, 430(1):375-380
7. Zhong Z, Chen X, Tan W, et al. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol, 2011,667(1-3):50-55
8. Deng C, Ji J, Li N, et al. Fast determination of curcumol, curdione and germacrone in three species of Curcuma rhizomes by microwave-assisted extraction followed by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr A, 2006,1117(2):115-120
9. Liu Y, Wang W, Fang B, et al. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol, 2013,698:95-102
10. Shu M, Zhou Y, Zhu W, et al. Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells. Mol Oncol, 2011,5(3):265-272
11. Hedvat M, Huszar D, Herrmann A, et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell, 2009,16(6): 487-497
12. Yang J, Cai X, Lu W, et al. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett, 2013,328(2): 243-251
13. Heo JY, Kim HJ, Kim SM, et al. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Lett, 2011,308(1):71-80
14. Tsuyama N, Danjoh I, Otsuyama K, et al. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3. Biochem Biophys Res Commun, 2005,337(1):201-208
15. Li F, Fernandez PP, Rajendran P, et al. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett, 2010,292(2):197-207
16. Sen M, Joyce S, Panahandeh M, et al. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer. Clin Cancer Res, 2012,18(18):4986-4996
17. Yen CY, Chiu CC, Haung RW, et al. Antiproliferative effects of goniothalamin on Ca9-22 oral cancer cells through apoptosis, DNA damage and ROS induction. Mutat Res, 2012,747(2):253-258
18. Kim J, Lee YJ, Shin DS, et al. Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell. Bioorg Med Chem, 2011,19(24):7582-7589
19. Barrero AF, Herrador MM, Quilez del Moral JF, et al. Efficient synthesis of the anticancer beta-elemene and other bioactive elemanes from sustainable germacrone. Org Biomol Chem, 2011,9(4):1118-1125
20. Yan J, Chen G, Tong S, et al. Preparative isolation and purification of germacrone and curdione from the essential oil of the rhizomes of Curcuma wenyujin by highspeed counter-current chromatography. J Chromatogr A, 2005,1070(1-2):207-210
21. Kuroyanagi M, Shirota O, Sekita S, et al. Transannular cyclization of (4S,5S)-germacrone-4,5-epoxide into guaiane and secoguaiane-type sesquiterpenes. Nat Prod Commun, 2012,7(4):441-446
22. Shen Y, La Perle KM, Levy DE, et al. Reduced STAT3 activity in mice mimics clinical disease syndromes. Biochem Biophys Res Commun, 2005,330(1):305-309
23. Negoro S, Kunisada K, Tone E, et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res, 2000,47(4):797-805.
24. Tian Y, Zhang W, Xia D, et al. Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci, 2011,18:53
25. Haga S, Terui K, Zhang HQ, et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest, 2003,112(7): 989-998
26. Niu G, Wright KL, Ma Y, et al. Role of Stat3 in regulating p53 expression and function. Mol Cell Biol, 2005,25(17): 7432-7440
27. Kusaba M, Nakao K, Goto T, et al. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis. J Hepatol, 2007,47(4): 546-555
28. Sprinzl MF, Tappe D, Strand S, et al. Inhibition of JAK/STAT3 signalling leads to apoptosis of human hepatoma cells expressing a HCV replicon through ER stress-induced mechanisms. J Hepatol, 2005,42:167-168
29. Baba Y, Sonoda JI, Hayashi S, et al. Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med, 2012,4(3):452-458
30. Barry SP, Townsend PA, McCormick J, et al. STAT3 deletion sensitizes cells to oxidative stress. Biochem Biophys Res Commun, 2009,385(3):324-329 Project of Ministry of Science and Technology